Clinical Trials Directory

Trials / Completed

CompletedNCT06978010

Efficacy of Platelet-rich Plasma in Improving Postoperative Scarring After Cesarean Delivery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Saint Andrew Hospital Constanta · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Cesarean section often leads to postoperative scarring, which can impact both physical and psychological well-being. Platelet-rich plasma (PRP), rich in growth factors, is used in regenerative medicine to promote healing and reduce inflammation.

Detailed description

Background: Cesarean section often leads to postoperative scarring, which can impact both physical and psychological well-being. Platelet-rich plasma (PRP), rich in growth factors, is used in regenerative medicine to promote healing and reduce inflammation. Objective: To evaluate the efficacy of intraoperative PRP in accelerating scar healing after cesarean section, using: Six visual scar assessment scales (Manchester, POSAS, Vancouver, VAS, NRS, REEDA) Hematological parameters (hemoglobin, hematocrit, leukocytes, platelets) Methods: Design: Prospective clinical study, 100 patients undergoing cesarean section with intraoperative PRP. Intervention: 10 ml PRP administered intraoperatively (5 ml before hysterography, 5 ml subcutaneously before skin closure). Assessments: Scar evaluation at day 7 and day 40 post-op using six scar scales; hematological parameters measured at both time points. Statistics: Wilcoxon paired samples test and Pearson correlation.

Conditions

Interventions

TypeNameDescription
OTHERPlatelet-Rich Plasma (PRP) intraoperativelyPatients receive platelet-rich plasma (PRP) intraoperatively during cesarean section (5 ml before hysterography, 5 ml subcutaneously before skin closure).

Timeline

Start date
2023-02-01
Primary completion
2024-01-31
Completion
2024-01-31
First posted
2025-05-18
Last updated
2025-05-21

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT06978010. Inclusion in this directory is not an endorsement.